Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 37 (1) , 90-94
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Dosage Patterns in Methadone Treatment: Results from a National Survey, 1988–2005Health Services Research, 2008
- State policy influence on the early diffusion of buprenorphine in community treatment programsSubstance Abuse Treatment, Prevention, and Policy, 2008
- Treatment programs in the National Drug Abuse Treatment Clinical Trials NetworkDrug and Alcohol Dependence, 2008
- Role of State Policies in the Adoption of Naltrexone for Substance Abuse TreatmentHealth Services Research, 2007
- Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward BuprenorphineThe American Journal on Addictions, 2007
- Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials NetworkJournal of Substance Abuse Treatment, 2007
- Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and BeliefsPsychiatric Services, 2007
- Trends in the Adoption of Medications for Alcohol DependenceJournal of Clinical Psychopharmacology, 2006
- Changes in Methadone Treatment PracticesJAMA, 2002
- Variations in Methadone Treatment PracticesJAMA, 1992